Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Brábek

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|December 7, 2017
Cancer, checkpoint inhibitors, and confusionMichael Fernandes, Jan Brábek
The Lancet. Oncology|January 10, 2012
Affordable cancer careJan Brábek, Michael Fernandes
In Vivo (Athens, Greece)|June 7, 2020
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic ImplicationsKarel Smetana, Jan Brábek
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2004
Assaying protein kinase activityJan Brábek, Steven K Hanks
In Vivo (Athens, Greece)|September 3, 2020
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and MortalityKarel Smetana, Daniel Rosel, Jan BrÁbek
British Journal of Cancer|August 21, 2019
Solid cancer: the new tumour spread endpoint opens novel opportunitiesMichael Fernandes, Daniel Rosel, Jan Brábek
The New England Journal of Medicine|January 7, 2017
Limits to Precision Cancer MedicineMichael Fernandes, Daniel Rosel, Jan Brábek
International Journal of Molecular Sciences|October 23, 2020
A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18Michal Dibus, Jan Brábek, Daniel Rösel
Oncotargets and Therapy|April 23, 2016
Pragmatic medicine in solid cancer: a translational alternative to precision medicineJan Brábek, Daniel Rosel, Michael Fernandes
Cancer Letters|March 2, 2026
Cancer invasion plasticity during the metastatic cascade: strategies to survive and thriveAneta Škarková, Daniel Rösel, Jan Brábek
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|December 7, 2017
Cancer, checkpoint inhibitors, and confusionMichael Fernandes, Jan Brábek
The Lancet. Oncology|January 10, 2012
Affordable cancer careJan Brábek, Michael Fernandes
In Vivo (Athens, Greece)|June 7, 2020
Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic ImplicationsKarel Smetana, Jan Brábek
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2004
Assaying protein kinase activityJan Brábek, Steven K Hanks
In Vivo (Athens, Greece)|September 3, 2020
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and MortalityKarel Smetana, Daniel Rosel, Jan BrÁbek
British Journal of Cancer|August 21, 2019
Solid cancer: the new tumour spread endpoint opens novel opportunitiesMichael Fernandes, Daniel Rosel, Jan Brábek
The New England Journal of Medicine|January 7, 2017
Limits to Precision Cancer MedicineMichael Fernandes, Daniel Rosel, Jan Brábek
International Journal of Molecular Sciences|October 23, 2020
A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18Michal Dibus, Jan Brábek, Daniel Rösel
Oncotargets and Therapy|April 23, 2016
Pragmatic medicine in solid cancer: a translational alternative to precision medicineJan Brábek, Daniel Rosel, Michael Fernandes
Cancer Letters|March 2, 2026
Cancer invasion plasticity during the metastatic cascade: strategies to survive and thriveAneta Škarková, Daniel Rösel, Jan Brábek
Pageof 9